NCT02875379

Brief Summary

Background. Non invasive positive pressure ventilation (NIV) is among first line treatments of acute respiratory failure. Several interfaces are available for non-invasive ventilation.Despite full face and oronasal masks are more frequently used, some evidence suggests that helmets may optimize patients' comfort and NIV tolerability. During NIV, humidification strategies (heat and moisture exchangers HME or heated humidifiers HH) may significantly affect patient's comfort and work of breathing. Despite physiological data suggested heated humidification as the best strategy during NIV with full face masks, no differences were found in a randomized controlled study assessing the effects of HME or HH on a pragmatic clinical outcome. However, the higher dead space (i.e. 18 L/min) and rebreathing rate observed during helmet NIV make such results not applicable to this particular setting. The investigators designed a randomized-crossover trial to assess the effect of four humidification strategies during helmet NIV on patients with acute respiratory failure, in terms of comfort, work of breathing and patient-ventilator interaction. Methods. All awake, collaborative, hypoxemic patients requiring mechanical ventilation will be considered for the enrollment. Hypercapnic patients (i.e.PaCO2\>45 mmHg) will be excluded. Each enrolled patient will undergo helmet NIV with all the following humidification strategies in a random order. Each period will last 60 minutes.

  • Passive humidification, double tube circuit.
  • Heated humification (MR 730, Fisher \& Paykel, Auckland, New Zealand), humidification chamber temperature 33°C.
  • Heated humification (MR 730, Fisher \& Paykel, Auckland, New Zealand), humidification chamber temperature 37°C.
  • Passive humidification with HME, Y-piece circuit. Ventilatory settings (Draeger Evita xl or Evita infinity ventilators): Pressure support ventilation; pressure support=20 cmH20; FiO2 titrated to obtain SpO2 between 92 and 98%; positive end-expiratory pressure=10 cmH2O; maximum inspiratory time 0.9 seconds; inspiratory flow trigger = 2 l/min; expiratory trigger: 30% of the maximum inspiratory flow; pressurization time=0,00 s. Such settings will be kept unchanged during the whole study period. An oesophageal catheter will be placed and secured to measure oesophageal pressure (Pes) and gastric pressure (Pga) (Nutrivent, Italy): the reliability of the measured pressure will be confirmed with an airway occlusion test during NIV with oronasal mask. Work of breathing will be estimated with the pressure-time product (PTP) of the pleural pressure. A pneumotachograph (KleisTek) will record flow, airway pressure, Pes and Pga on a dedicated laptop. At the end of each cycle, the patient will be asked to rate his/her discomfort on a visual analog scale (VAS) modified for ICU patients. The level of dyspnea will be assessed with the Borg dyspnea scale. The following parameters will be record at the end of each cycle: Arterial pressure, heart rate, respiratory rate, SpO2, pH, PCO2, PaO2, SaO2. Airway and esophageal pressure signals will be reviewed offline to detect patient-ventilator asynchronies (ineffective efforts, double cycling, premature cycling, delayed cycling) and asynchrony index (number of asynchrony events divided by the total respiratory rate computed as the sum of the number of ventilator cycles (triggered or not) and of wasted efforts) will be computed. The trigger delay will be also measured. The pressurization and depressurization velocity will be assessed with the PTP airway index 300 and 500 (inspiratory and expiratory), as suggested by Ferrone and coworkers. The work of breathing (WOB) for each breath will be estimated by PTPes. An hygrometer (Dimar SRL, Italy) will measure and record on a dedicated laptop Helmet temperature, relative and absolute humidity. Primary endpoints: patient's comfort, work of breathing and asynchrony index. Sample Sizing: Given the physiological design of the study, the investigators did not make an a priori sample size and plan to enroll 24 patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2015

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

August 23, 2016

Completed
5 months until next milestone

Study Start

First participant enrolled

February 1, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 23, 2019

Completed
Last Updated

January 24, 2019

Status Verified

January 1, 2019

Enrollment Period

2 years

First QC Date

July 27, 2015

Last Update Submit

January 23, 2019

Conditions

Keywords

Noninvasive VentilationMechanical Ventilation

Outcome Measures

Primary Outcomes (3)

  • Comfort assessed by visual analogic scale modified for ICU patients

    Patient's comfort, assessed by visual analogic scale modified for ICU patients

    At the end of each 1-hour ventilation period

  • Patient-ventilator asynchrony. Asynchrony index

    Asynchrony index number of asynchrony events divided by the total respiratory rate computed as the sum of the number of ventilator cycles (triggered or not) and of wasted efforts. Inspiratory trigger delay (time between the onset of patient's effort and ventilatory support). Pressurization and depressurization efficacy.

    At the end of each 1-hour ventilation period

  • Work of breathing. Oesophageal pressure time product

    Pressure time product of the esophageal pressure (PTPes) and pressure time product of the transdiaphragmatic pressure (PTPdi)

    At the end of each 1-hour ventilation period

Secondary Outcomes (6)

  • PaO2

    At the end of each 1-hour ventilation period

  • respiratory rate

    At the end of each 1-hour ventilation period

  • Dyspnea

    At the end of each 1-hour ventilation period

  • Helmet humidity

    At the end of each 1-hour ventilation period

  • Helmet temperature

    At the end of each 1-hour ventilation period

  • +1 more secondary outcomes

Study Arms (4)

HME

EXPERIMENTAL

Passive humidification with heat and moisture exchanger, Y-piece circuit.

Procedure: Measurements

HH33

EXPERIMENTAL

Heated humification (MR 730, Fisher \& Paykel, Auckland, New Zealand), humidification chamber temperature 33°C.

Procedure: Measurements

HH37

EXPERIMENTAL

Heated humification (MR 730, Fisher \& Paykel, Auckland, New Zealand), humidification chamber temperature 33°C.

Procedure: Measurements

NoH

EXPERIMENTAL

Passive humidification, double tube circuit

Procedure: Measurements

Interventions

MeasurementsPROCEDURE

Measurements of respiratory mechanics and parameters, arterial blood gases and comfort

HH33HH37HMENoH

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Awake and collaborative patients
  • Age\>18 years
  • Need for noninvasive mechanical ventilation
  • Informed consent

You may not qualify if:

  • Cardiopulmonary resuscitation
  • Haemodynamic instability
  • Coma
  • Asma
  • Hypercapnia (paCO2\>45 mmHg)
  • Recent gastric or abdominal surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General ICU, A. Gemelli hospital

Rome, 00100, Italy

Location

Related Publications (1)

  • Bongiovanni F, Grieco DL, Anzellotti GM, Menga LS, Michi T, Cesarano M, Raggi V, De Bartolomeo C, Mura B, Mercurio G, D'Arrigo S, Bello G, Maviglia R, Pennisi MA, Antonelli M. Gas conditioning during helmet noninvasive ventilation: effect on comfort, gas exchange, inspiratory effort, transpulmonary pressure and patient-ventilator interaction. Ann Intensive Care. 2021 Dec 24;11(1):184. doi: 10.1186/s13613-021-00972-9.

MeSH Terms

Conditions

Respiratory Insufficiency

Interventions

Weights and Measures

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D. Full Professor of Anesthesiology and Intensive Care. Head of the department of Anesthesiology and Intensive Care medicine

Study Record Dates

First Submitted

July 27, 2015

First Posted

August 23, 2016

Study Start

February 1, 2017

Primary Completion

January 23, 2019

Study Completion

January 23, 2019

Last Updated

January 24, 2019

Record last verified: 2019-01

Locations